PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth Article (Web of Science)

Open Access

cited authors

  • Bhattacharjee, Sayani; Sullivan, Matthew J.; Wynn, Rebecca R.; Demagall, Alex; Hendrix, Andrew S.; Sindhwani, Puneet; Petros, Firas G.; Nadiminty, Nagalakshmi

authors

publication date

  • March 23, 2022

webpage

published in

category

keywords

  • Bladder cancer
  • Cisplatin
  • Combination therapy
  • DNA damage repair
  • PARP inhibition
  • Urothelial carcinoma

volume

  • 22

issue

  • 1